Physician profile
Hannah Bailey
NPI 1619223443
$1,818.90
in general payments reported to CMS, 2019-2025
23 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $81.60 · 2021: $243 · 2022: $163 · 2023: $302 · 2024: $591 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.55 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $394.77 | 2023-2025 | Veozah |
| Gilead Sciences, INC. | $214.34 | 2021-2024 | |
| Amgen INC. | $184.71 | 2019-2024 | Prolia, Evenity |
| Exeltis, USA INC. | $152.95 | 2022-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $111.21 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $89.36 | 2021-2025 | |
| Pfizer INC. | $80.76 | 2023-2024 | |
| Agile Therapeutics, INC. | $76.95 | 2021-2023 | Twirla |
| Baxter Healthcare | $58.39 | 2024 | Perclot |
| Hologic Sales and Service, LLC | $48.98 | 2024-2025 | Novasure, Aptima |
| Aspira Women'S Health INC | $48.39 | 2025 | Ova1 |
| Abbvie INC. | $45.72 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Organon LLC | $45.47 | 2022-2024 | |
| Coopersurgical, INC. | $42.12 | 2025 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $33.11 | 2021-2025 | Gardasil 9 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $32.28 | 2025 | |
| Ge Healthcare | $30.00 | 2021 | |
| Ethicon US, LLC | $26.36 | 2025 | Stratafix, Ethicon, Vistaseal |
| Becton, Dickinson and Company | $25.82 | 2024 | Arista Ah Flexitip |
| Evofem Biosciences, INC. | $23.69 | 2021 | |
| Daiichi Sankyo INC. | $18.38 | 2022 | |
| Novo Nordisk INC | $17.74 | 2025 | Ozempic |
| Avion Pharmaceuticals | $17.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.